FDA label
What is Ilevro used for?
Ilevro contains nepafenac. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ILEVRO ®0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Ilevro?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ilevro, suspension/ drops
Indications and Usage, quoted from the label by Novartis Pharmaceuticals Corporation (NDA203491). Cross-references to other label sections are left out.
ILEVRO ®0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.
Source: DailyMed label, set id f089b583-0310-4ca8-8d41-52b06b08d1ed, version 5, effective April 1, 2026. NDC 0078-0743, one of 2 listings for this product.
Questions
What is Ilevro used for?
The FDA label says: “ILEVRO ®0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.”
What drug class is Ilevro?
FDA lists nepafenac in the Nonsteroidal Anti-inflammatory Drug established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.